HLA-DRA Antikörper (AA 27-216)
-
- Target Alle HLA-DRA Antikörper anzeigen
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Bindungsspezifität
- AA 27-216
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HLA-DRA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Verwendungszweck
- Polyclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
- Spezifität
- The antibody is a rabbit polyclonal antibody raised against HLA-DRA. It has been selected for its ability to recognize HLA-DRA in immunohistochemical staining and western blotting.
- Kreuzreaktivität
- Maus, Schwein
- Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Immunogen
- Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) corresdonding to Lys27~Glu216 with N-terminal His Tag
- Isotyp
- IgG
- Top Product
- Discover our top product HLA-DRA Primärantikörper
-
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-254) antibody
HLA-DRA Reaktivität: Human WB, FACS, ELISA, ICC Wirt: Maus Monoclonal 1C11A5 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-216) antibodyHLA-DRA Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 1-254) antibodyHLA-DRA Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human FACS, IHC, IF, StM Wirt: Maus Monoclonal 19-26-1-same as MB-26-1 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human, Ratte, Maus WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human IHC Wirt: Kaninchen Monoclonal MSVA-470R unconjugated Recombinant Antibody
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-221) antibodyHLA-DRA Reaktivität: Kaninchen WB, IHC, IP, ICC Wirt: Meerschweinchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 149-177), (C-Term) antibodyHLA-DRA Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB19527 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 1-254) antibodyHLA-DRA Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
-
Western blotting: 0.5-3 μg/mL
Immunohistochemistry: 5-30 μg/mL
Immunocytochemistry: 5-30 μg/mL
Optimal working dilutions must be determined by end user.
- Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 24 months
-
- Target
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
- Andere Bezeichnung
- HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA Produkte)
- Hintergrund
- MHCDRa, HLADRa, Major Histocompatibility Complex Class II DR Alpha
- Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-
